Lightstone Ventures — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Amber Therapeuticsamber-tx.cominSeries A · Jun 2024 · $100M
Amber Therapeutics develops medical technology focused on treating mixed urinary incontinence, advancing toward pivotal clinical trials in the US with expanded feasibility studies in Europe.
Medical Devices
Co-investorsF-Prime CapitalIntuitive VenturesNew Enterprise Associates (NEA)Oxford Science Enterprises
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.